4.6 Article

Pivotal role for decorin in angiogenesis

Journal

MATRIX BIOLOGY
Volume 43, Issue -, Pages 15-26

Publisher

ELSEVIER
DOI: 10.1016/j.matbio.2015.01.023

Keywords

Angiogenesis; Extracellular matrix; Proteoglycan; Decorin; Mechanism; Therapy

Funding

  1. Medical Research Fund of Turku University Hospital
  2. Cancer Foundation of South-Western Finland
  3. Turku University Foundation Fund of Turku University
  4. Finnish Foundation for Cardiovascular Research
  5. National Institutes of Health [R01 HL064387, EB 012558]

Ask authors/readers for more resources

Angiogenesis, the formation of new blood vessels from preexisting vessels, is a highly complex process. It is regulated in a finely-tuned manner by numerous molecules including not only soluble growth factors such as vascular endothelial growth factor and several other growth factors, but also a diverse set of insoluble molecules, particularly collagenous and non-collagenous matrix constituents. In this review we have focused on the role and potential mechanisms of a multifunctional small leucine-rich proteoglycan decorin in angiogenesis. Depending on the cellular and molecular microenvironment where angiogenesis occurs, decorin can exhibit either a proangiogenic or an antiangiogenic activity. Nevertheless, in tumorigenesis-associated angiogenesis and in various inflammatory processes, particularly foreign body reactions and scarring, decorin exhibits an antiangiogenic activity, thus providing a potential basis for the development of decorin-based therapies in these pathological situations. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro

Marie C. Nyman, Annele O. Sainio, Mirka M. Pennanen, Riikka J. Lund, Sanna Vuorikoski, Jari T. T. Sundstrom, Hannu T. Jarvelainen

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)

Article Multidisciplinary Sciences

Epigenetic Silencing of the Key Antioxidant Enzyme Catalase in Karyotypically Abnormal Human Pluripotent Stem Cells

Mikko Konki, Kalyan Pasumarthy, Maia Malonzo, Annele Sainio, Cristina Valensisi, Mirva Soderstrom, Maheswara Reddy Emani, Aki Stubb, Elisa Narva, Bishwa Ghimire, Asta Laiho, Hannu Jarvelainen, Riitta Lahesmaa, Harri Lahdesmaki, R. David Hawkins, Riikka J. Lund

SCIENTIFIC REPORTS (2016)

Review Pharmacology & Pharmacy

Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers

Annele Orvokki Sainio, Hannu Tapio Jarvelainen

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis

Annele Sainio, Tiina Jokela, Markku I. Tammi, Hannu Jarvelainen

GLYCOBIOLOGY (2010)

Article Cell Biology

Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast

Pia Bostrom, Annele Sainio, Tanja Kakko, Mikko Savontaus, Mirva Soderstrom, Hannu Jarvelainen

HISTOCHEMISTRY AND CELL BIOLOGY (2013)

Article Multidisciplinary Sciences

Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies

Annele Sainio, Marie Nyman, Riikka Lund, Sanna Vuorikoski, Pia Bostrom, Matti Laato, Peter J. Bostrom, Hannu Jarvelainen

PLOS ONE (2013)

Article Medicine, Research & Experimental

Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: Relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study

Mervi Oikonen, Maria Wendelin-Saarenhovi, Niina Siitonen, Annele Sainio, Markus Juonala, Mika Kahonen, Leo-Pekka Lyytikainen, Ilkka Seppala, Terho Lehtimaki, Jorma S. A. Viikari, Hannu Jarvelainen, Olli T. Raitakari

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)

Article Cell Biology

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells

Marie C. Nyman, Anne B. Jokilammi, Pia C. Bostrom, Samu H. Kurki, Annele O. Sainio, Seija E. Grenman, Katri J. Orte, Sakari H. Hietanen, Klaus Elenius, Hannu T. Jarvelainen

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)

Article Medicine, General & Internal

Metformin decreases hyaluronan synthesis by vascular smooth muscle cells

Annele Sainio, Piia Takabe, Sanna Oikari, Henriikka Salomaki-Myftari, Markku Koulu, Mirva Soderstrom, Sanna Pasonen-Seppanen, Hannu Jarvelainen

JOURNAL OF INVESTIGATIVE MEDICINE (2020)

Article Cell Biology

Extracellular matrix-cell interactions: Focus on therapeutic applications

A. Sainio, H. Jarvelainen

CELLULAR SIGNALLING (2020)

Article Medicine, Research & Experimental

Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryos

Roope Huttunen, Annele Sainio, Anja Hjelt, Anna-Mari Haapanen-Saaristo, Jorma Maatta, Petri Rummukainen, Ilkka Paatero, Hannu Jarvelainen

Summary: The SGLT2 inhibitor canagliflozin increases the risk for lower limb amputations in type 2 diabetics, while empagliflozin and dapagliflozin do not have the same effect. The study using zebrafish and human umbilical vein endothelial cells (HUVECs) found that different SGLT2 inhibitors have varying effects on angiogenesis and cell viability, indicating that the risk for peripheral amputations may differ among SGLT2 inhibitors.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Meeting Abstract Pathology

Human breast cancer and decorin

A. Sainio, P. Bostrom, N. Eigeliene, I. Koskivuo Section, H. Jarvelainen

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2017)

Article Oncology

Human Metaplastic Breast Carcinoma and Decorin

Pia Bostrom, Annele Sainio, Natalja Eigeliene, Anne Jokilammi, Klaus Elenius, Ilkka Koskivuo, Hannu Jarvelainen

CANCER MICROENVIRONMENT (2017)

Article Ophthalmology

A novel double nucleotide variant in the ferritin-L iron-responsive element in a Finnish patient with hereditary hyperferritinaemia-cataract syndrome

Roosa-Maria Mattila, Annele Sainio, Marketta Jarvelainen, Juha Pursiheimo, Hannu Jarvelainen

ACTA OPHTHALMOLOGICA (2018)

No Data Available